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Abstract Melatonin (MEL) plays a central role in the 
regulation of seasonal cycles and in the control of circadian 
rhythms in mammals. Functional MEL-sensitive receptors were 
expressed in Xenopus laevis oocytes following injection of poly 
(A) ÷ RNA from rat brain. Administration of 0.1-100 ~tmolfl 
MEL to voltage-clamped oocytes (holding potential: -70  mV) 
elicited oscillatory inward currents (reversal potential: -24  mV) 
which could be blocked by 9-anthracenecarboxylic acid and 
caffeine. After preincubation with pertussis toxin (PTX) the 
MEL response disappeared. The expressed MEL-sensitive 
receptor probably activates Ca2÷-dependent chloride currents 
via a PTX-sensitive G protein and the phosphoinositol pathway. 
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1. Introduction 
Melatonin (MEL) plays a central role in the regulation of 
seasonal cycles and in the control of circadian rhythms in 
mammals [1]. The distribution pattern of MEL receptors in 
the central nervous system of different species has been stud- 
ied intensively over the last few years [2]. MEL binding sites 
were found in the pars tuberalis and the nucleus suprachias- 
maticus in all tested mammals including humans [3]. Addi- 
tional binding sites for MEL  were detected in the parietal 
cortex of the rabbit and in the hippocampus of the bovine, 
ovine, rabbit and several primates [4-7]. In humans, MEL 
receptors were additionally found in the cerebellum and in 
the frontal cortex [8,9]. 
The MEL  receptors are functionally coupled to G-proteins 
which inhibit the activity of the adenylyl cyclase [10]. The 
activation of MEL receptors causes a reduction of the forsko- 
lin-stimulated cAMP level in the cells [2,7]. Recently cloned 
MEL  receptors from Xenopus laevis melanophores and from 
mammalian pars tuberalis and hypothalamus of different 
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Abbreviations: MEL, melatonin; G protein, guanyl nucleotide binding 
protein; cAMP, cyclic adenosine 5'-monophosphate; PTX, pertussis 
toxin; IP3, inositol 1,4,5-triphosphate; DMSO, dimethyl sulfoxide; 9- 
AC, 9-anthracenecarboxylic acid; Tris, Tris(hydroxymethyl)amino- 
methane; BSA, bovine serum albumine; HEPES, N-(2-hydroxyethyl)- 
piperazine-N'-2-ethane sulfonic acid. 
mammals also inhibit, after their stable expression in a mam- 
malian cell line, the forskolin-induced cAMP elevation [11]. 
There are several hints indicating that MEL binds to recep- 
tors with different structural and pharmacological properties. 
Barrett et al. [12] isolated a solubilized Mel receptor/G-protein 
complex which was structurally different from the pars tuber- 
alis solubilized complex. Furthermore, it has been shown that 
MEL is linked to the phosphoinositol second messenger path- 
way [13]. 
The majority of the investigations are based on data from 
binding studies and molecular cloning experiments. There are, 
however, only a few electrophysiological studies that have 
investigated the way in which MEL affects neuronal cells 
[7]. Studies on the nature of the pharmacological nd electro- 
physiological activity of MEL in nervous tissue are hampered 
by the complexity of the central nervous system. For this 
reason we investigated by electrophysiological techniques the 
action of MEL-sensitive receptors on Xenopus oocytes, pre- 
viously microinjected with mRNA from rat brain. This ex- 
pression system allows the analysis at the level of single cells 
under controlled condition. 
2. Materials and methods 
2.1. Materials 
Melatonin, forskolin and caffeine were purchased from Sigma and 
9-AC from Merck. 2-[125j]iodomelatonin (1600-2000 Ci) was obtained 
from Amersham (Germany). PTX was a gift from Prof. A. Schmidt, 
Westf'~ilische Wilhelms-Universit/it, Institut f~r Infektiologie, Mfinster. 
2.2. Autoradiography 
To determine the pattern of melatonin binding sites, brains of adult 
rats were rapidly removed, frozen in isopentan on dry ice at -30°C. 
Sections (20 p.m) were cut on a cryostat at -20°C and stored at 
-80°C until processed for autoradiography as described previously 
[14]. Briefly, sections were preincubated in Tris-BSA buffer (50 
mmol/1 Tris-HCl, 4 mmol/l CaCI2, 0.05% BSA, pH 7.4 at 25°C) and 
then incubated in the same buffer containing 10(~120 pmol/l 2- 
[125j]iodomelatonin in the presence or absence of 0.1 gmol/1 unlabeled 
MEL. After 90 min sections were washed in Tris-BSA buffer and Tris 
buffer without BSA at 4°C for 15 min and dipped in ice cold distilled 
water for 15 s. Afterwards they were air dried and exposed for 15 days 
to a ~H-film. Films were developed according to the instruction of the 
manufacture (Amersham). Adjacent sections were stained with cresyl 
violet and examined by light microscopy for morphological correla- 
tion of binding sites. 
2.3. Expression system 
Total RNA was isolated from total brain of adult rats using a 
guanidine/LiC1 method [15]. Poly(A) + RNA was prepared by column 
chromatography on oligo-(dT) cellulose according to the manufac- 
turer's instructions (Pharmacia). The poly(A) + RNA was dissolved 
in distilled water at a concentration of 1 mg/ml and stored at 
-20°C until injection. Small parts of the ovary were taken from adult 
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Xenopus laevis under anaesthesia (5 mmol/1 ethyl m-aminobenzoate; 
Sandoz). Stage V or VI oocytes [16] were manually dissected and each 
injected with 50 ng poly(A) ÷ RNA. The injected oocytes were main- 
tained under tissue culture conditions in a modified Barth medium 
composed of (in mmol/l): NaC1 88, CaC12 1.5, KCI 1, NaHCO3 2.4, 
MgSO4 0.8, HEPES 5; pH 7.4; temperature 20°C. The medium was 
supplemented with penicillin (100 IU/ml) and streptomycin (100 lag/ 
ml). For some investigations follicular cells surrounding the oocytes 
were removed by manual dissection with forceps. 
2.4. Electrophysiology 
The electrophysiological investigations were performed from day 3 
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Fig. 2. Membrane currents of three different oocytes (Xenopus lae- 
vis) elicited by administration of 10 gmol/1 MEL. Recordings 4 days 
after injection of poly (A)+-RNA from rat brain. Administration is 
marked by horizontal bars. Holding potential: -70  mV. Inward 
current: downward deflection. Asterisk: stream evoked inward cur- 
rent [21]. 
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Fig. 1. Autoradiography of 2-[125J]iodomelatonin binding sites in 
the rat brain. A: Cresyl violet stained horizontal section. B: Specific 
125 binding with 2-[ J]iodomelatonin. C: Unspecific binding in the pre- 
sence of 0.1 moll1 unlabelled MEL. Bar: 5 mm. 
measured using a standard two microelectrode voltage clamp techni- 
que. The current and voltage electrodes were filled with 2 mol/l KC1 
(resistances: 1 to 2 Mr2). Unless otherwise noted, membrane currents 
were measured at a holding potential of -70  mV. The control bath 
fluid was a salt solution composed of (in mmol/1): NaC1 115, KC1 2, 
CaC12 1.8, HEPES 10; pH 7.2. Forskolin (1 gmol/l), 9-AC (2 mmol/1) 
and caffeine (1 mmol/1) were dissolved in the control bath solution. 10 
mmol/1 MEL was dissolved in DMSO and this stock solution was 
diluted immediately prior to experiments with the control bath solu- 
tion to give final concentrations of MEL of 0.1 100 gmol/l (DMSO 
concentration: 0.0001°/o-0.1%). The solutions were administered ex- 
tracellularly to the oocytes using a concentration clamp technique 
[17]. To test the effects of PTX on the MEL response, mRNA-injected 
oocytes, tested for MEL sensitivity, were incubated for 17 h in a 
modified Barth medium in which PTX was dissolved at a concentra- 
tion of 5 gg/ml. 
3. Results 
3.1. Pattern o f  MEL  binding sites in the rat brain 
The distr ibut ion of  specific [125I]MEL b inding sites was re- 
100 
stricted to a few sites in the rat brain. Intense labelling was 
observed only in the pars tuberalis and in the suprachiasmatic 
nuclei (data not shown) and additionally in the hippocampus 
(Fig. 1). Although the resolution of the autoradiography may 
not be sufficient o detect the MEL  binding sites on the cel- 
lular level, the localization of the binding sites in the hippo- 
campus seems to be restricted to the subicular region. The 
nonspecific binding was near the background. 
3.2. Expression of melatonin-sensitive r ceptors in 
microinjected oocytes 
Oocytes of 20 different donors were injected with rat brain 
poly (A)+-RNA from 10 different batches. Injection of the 
RNA into the oocytes led to the functional expression of 
various ligand operated ion channels. The pharmacological 
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Fig. 3. Membrane currents of a single oocyte (Xenopus laevis) eli- 
cited by MEL (A; control reaction) and effects of caffeine (B), 9- 
AC (C) and PTX pretreatment (D) on the MEL response. Record- 
ings 4 days after injection of poly (A)+-RNA from rat brain. Con- 
centration of the substances: MEL 10 ~tmol/1, caffeine 1 mmol/1, 9- 
AC 2 mmol/1 and PTX 5 ktg/ml (incubation time of PTX: 17 h). 
Administration of substances are marked by horizontal bars. Hold- 
ing potential: -70 mV. Inward current: downward eflection. 
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Fig. 4. Membrane currents of a single oocyte (Xenopus laevis) eli- 
cited by forskolin (A) and interaction of forskolin and MEL with 
simultaneous administration (B). Recordings 4 days after injection 
of poly (A)+-RNA from rat brain. Concentration of the ligands: 
MEL 100 IxmoF1, forskolin 1 lamol/1. The oscillatory inward currents 
of the oocytes evoked by MEL were blocked by 2 mmol/1 9-AC in 
the background. Administration is marked by horizontal bars. 
Holding potential: -70 mV. Inward current: downward eflection. 
screening demonstrated that the injected oocytes expressed 
receptors ensitive to the neurotransmitters gamma-aminobu- 
tyric acid, glutamate, dopamine and serotonine (data not 
shown; [18,19]). 
The administration of MEL to the RNA-injected oocytes 
evoked oscillatory inward currents (Fig. 2; n = 62), whereas 
native oocytes or water-injected oocytes did not respond to 
either MEL  or other transmitters (n = 30). The time course of 
expression of MEL-sensitive receptors in oocytes following 
mRNA injection was similar to that observed for other recep- 
tors [20]. Maximum reponses occurred between 3 and 5 days 
following mRNA injection. Original recordings from three 
RNA-injected oocytes are shown in Fig. 2. The delay between 
application of MEL  and onset of the current response showed 
some degree of variability. In most cases the MEL response 
occurred within 20 to 30 s, but in some cells it took more than 
60 s before the current oscillations tarted to rise. The oscilla- 
tions persisted for several minutes, sometimes for more than 
1 h, regardless of whether the MEL  application continued or 
had been stopped. With wash-out of MEL  or control solution 
during current oscillations the so called 'stream evoked' in- 
ward current appeared (asterisk in Fig. 2; [21]). The response 
to MEL was dose dependent. The minimum concentration 
needed to evoke MEL responses was 0.1 gmol/1, maximum 
responses appeared with applications of 100 gmol/l MEL. The 
MEL response persisted even after removal of the outer folli- 
cular layers (n = 5). The response was not caused by the sol- 
vent DMSO since application of DMSO (0.1%) alone did not 
elicit membrane currents (n -- 18). 
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3.3. Electrophysiological characterization of the MEL-induced 
inward currents 
The reversal potential of the MEL-induced oscillatory in- 
ward currents was found to be -24  mV (n = 6) which corre- 
sponds to the equilibrium potential for C1- ions in oocytes 
[22]. The oscillatory current could be based on the Ca2+-acti - 
vated C1- currents that can be evoked in Xenopus oocytes via 
the phosphoinositol-dependent s cond messenger pathway 
[22]. To test for this, the chloride channel blocking substance 
9-AC and caffeine, which inhibits IPa-mediated release of in- 
tracellular calcium [23], were applied before, during and after 
MEL application. As shown in Fig. 3, both substances com- 
pletely blocked the MEL response (Fig. 3B,C; n= 3). With 
preincubation of mRNA-injected oocytes in a Barth medium 
containing PTX the MEL response disappeared (Fig. 3D; 
n= 12). 
3.4. Effects of  MEL on the cyclic AMP pathway 
It has been reported that in the cells of the pars tuberalis 
MEL-sensitive receptors are functionally coupled to a G pro- 
tein, which causes a decrease in the cyclic AMP level [2,7,10]. 
To test whether the expressed MEL-sensitive receptors are 
additionally able to influence the cyclic AMP level in oocytes, 
the effects of MEL on the action of forskolin, an unspecific 
activator of the adenylyl cyclase, was tested. The application 
of forskolin to mRNA-injected oocytes evoked a slow onset, 
smooth and long lasting outward current (Fig. 4A; n = 6). The 
current has a reversal potential of about --105 mV (n=3) 
which is close to the equilibrium potential of potassium ions 
in oocytes [22]. These data are in line with investigations of
Greenfield et al. performed on oocytes, demonstrating that 
forskolin increased the potassium conductance via elevation 
of the cyclic AMP level [24]. The effect of MEL on the for- 
skolin-induced response was tested by simultaneous applica- 
tion of both MEL and forskolin. The oscillatory inward cur- 
rents evoked by MEL were blocked by continuous 
administration f 2 mmol/1 9-AC. There was no effect of 9- 
AC on the forskolin-induced outward current (n=4). The 
amplitude of the forskolin responses (17+4 nA; mean 
+ S.E.M.) was not significantly changed with simultaneous 
application of 100 gmol/1 MEL (18 + 5 nA; n =6; Fig. 4B). 
4. Discussion 
The present experiments demonstrate that injection of 
mRNA from rat brain into the heterologous Xenopus oocyte 
expression system results in the functional expression of a 
receptor sensitive to MEL. This MEL-sensitive receptor was 
determined to be exogenous ince native oocytes or water- 
injected oocytes were non responsive to MEL. Defolliculated 
mRNA-injected oocytes maintained their sensitivity to MEL, 
indicating that the MEL-sensitive receptor is integrated into 
the plasma membrane of the oocyte. This is further supported 
by the fact that follicle cells loss their functional integrity after 
a cultivation period of more than 3 days [25]. 
The MEL receptors are coupled to G proteins and their 
activation often leads to the inhibition of the adenylyl cyclase, 
resulting in a decrease in the cAMP level of the cells [2,7,10]. 
Recently it has been reported that MEL is also able to influ- 
ence the phosphoinositide breakdown in chicken brain slices 
[13]. Our experiments showed that the MEL-sensitive receptor 
expressed in oocytes did not inhibit the increase in the cAMP 
level induced by 1 gmol/l forskolin. The expressed receptor is 
obviously not coupled to an inhibitory G protein which re- 
duces the activity of the adenylyl cyclase. The current re- 
sponses to application of MEL may be interpreted as to be 
due to the activation of a PTX-sensitive G protein eliciting a 
Ca2+-dependent CI- current. This hypothesis supported by 
the findings that (i) the MEL response disappeared after PTX 
pretreatment of the oocytes, (ii) the current disappeared after 
incubation with caffeine, which inhibits IPa-mediated release 
of intracellular calcium, (iii) the equilibrium potential of the 
current was near to that of chloride, and (iv) the current was 
abolished after application of the chloride channel blocker 9- 
AC. Therefore, the expressed MEL-sensitive receptor may re- 
present a receptor type which is obviously linked to G pro- 
teins activating the phospholipase C and subsequently the 
phosphoinositol second messenger pathway of the cells. This 
receptor type may belong to the putative ML2 subtype pro- 
posed by Popova and Dubokovich [13]. 
To our knowledge there is only one report in literature 
using Xenopus oocytes to express MEL receptors. Fraser et 
al. [26] injected mRNA from the pars tuberalis of bovine 
pituitary into oocytes and reported that MEL reduced AIF4- 
induced current oscillations. This was shown for the RNA- 
injected oocytes as well as for native oocytes. However, the 
described effects were observed at a concentration f 1 mmol/1 
MEL. In the present experiments the expressed MEL-sensitive 
receptors derived from RNA of total rat brain are able to 
induce oscillatory current responses in a concentration range 
of MEL which is near to the physiological concentration mea- 
sured in mammals. The current response could be evoked at a 
minimum concentration of 100 nmol/1 MEL, whereas the 
physiological concentration i mammals is in the range of 
1 nmol/l [l]. 
The higher concentration f MEL needed to evoke detect- 
able ion currents in Xenopus oocytes may be due to the fact 
that the relative amount of specific mRNA and, as a conse- 
quence, the amount of functional MEL receptors expressed in 
oocytes are low. This is in line with the fact that specific 
[125I]MEL binding sites in the rat brain, as examined in ad- 
jacent sections by in vitro autoradiography, are restricted to a 
few sites (Fig. 1; see also [2]). 
The oocyte expression system is found to be a suitable tool 
to investigate new agonists and antagonists for the MEL-sen- 
sitive receptor and its specific subtype presented here. Further- 
more, this expression system can be used as part of a cloning 
strategy to identify and isolate the cDNA for this MEL-sen- 
sitive subreceptors. 
Acknowledgements: This study was supported by the Deutsche For- 
schungsgemeinschaft (Wi 55815-1). 
References 
[1] Reiter, R.J. (1986) J. Neural. Transm. 21, 35-54. 
[2] Morgan, P.J., Barrett, P., Howell, H.E. and Helliwell, R. (1994) 
Neurochem. Int. 24, 101-146. 
[3] Reppert, S.M., Weaver, D.R., Rivkees, S.A. and Stopa, S. (1988) 
Science 78, 242-249. 
[4] Stankov, B., Cozzi, B., Lucini, V., Capsoni, S., Fauteck, J.D., 
Fumagalli, P. and Fraschini, F. (1991) Neurosci. Lett. 133, 68 
77. 
[5] Morgan, P.J., Barrett, P., Hazlerigg, D., Milligan, G., Lawson, 
W., MacLean, A. and Davidson, G. (1995) J. Neuroendocrinol. 
7, 361-369. 
102 B. Fischer et al./FEBS Letters 381 (1996) 98-102 
[6] Nonno, R., Lucini, V., Stankov, B. and Fraschini, F. (1995) 
Neurosci. Lett. 194, 113-116. 
[7] Stankov, B., Capsoni, S., Lucini, V., Fauteck, J.-D., Gatti, S., 
Gridelli, B., Biella, G., Cozzi, B. and Fraschini, F. (1993) Neu- 
roscience 52, 459468. 
[8] Fautek, J.-D., Lerchl, A., Bergmann, M., Moiler, M., Fraschini, 
F. and Stankov, B. (1994) Neurosci. Lett. 179, 60-64. 
[9] Fauteck, J.-D., Bockmann, J., B6ckers, T.M., Wittkowski, W., 
K6hling, R., LiJcke, A., Straub, H., Speckmann, E.-J., Tuxhorn, 
I., Wolf, P., Panneck, H. and Oppel, F. Exp. Brain Res., in press. 
[10] Morgan, P.J., Lawson, W., Davidson, G. and Howell, H.E. 
(1989) J. Mol. Endocrinol. 3, R5-R8. 
[11] Reppert, S.M., Weaver, D.R. and Ebisawa, T. (1994) Neuron 13, 
1177-1185. 
[12] Barrett, P., MacLean, A. and Morgan, P.J. (1994) J. Neuroendo- 
crinol. 6, 509 515. 
[13] Popova, J.S. and Dubokovich, M.L. (1995) J. Neurochem. 64, 
130-138. 
[14] Stankov, B., Cozzi, B., Lucini, V., Fumagalli, P., Scaliogne, F. 
and Fraschini, F. (1991) Neuroendocrinol. 53, 214-225. 
[15] Cathala, C., Savouret, J.-F., Mendez, B., West, B.L., Karin, M., 
Martial, J.A. and Baxter, J.D. (1983) DNA 2, 329-335. 
[16] Dumont, J.N. (1972) J. Morphol. 136, 153-180. 
[17] Madeja, M., Mu[3hoff, U. and Speckmann, E.-J. (1991) J. Neu- 
rosci. Methods 38, 267-269. 
[18] Mu[3hoff, U., Madeja, M., Bloms, P., M~isch-Nittel, K. and 
Speckmann, E.-J. (1992) Neurosci. Lett. 147, 163 166. 
[19] Mu[3hoff, U., Madeja, M., Bloms-Funke, P. and Speckmann, E.- 
J. (1994) Brain Res. 639, 135-138. 
[20] Mu~hoff, U., Madeja, M., Bloms, P. and Speckmann, E.-J. 
(1992) Comp. Biochem. Physiol. 103C, 189-193. 
[21] Mu[3hoff, U., Madeja, M., Kuhlmann, D. and Speckmann E.-J. 
(1991) Neurosci. Lett. 125, 212~14. 
[22] Dascal, N. (1987) CRC Critical Rev. Biochem. 22, 317-387. 
[23] Parker, I. and Ivorra, I. (1991) J. Physiol. 433, 229-240. 
[24] Greenfield, L.J., Hackett, J.T. and Linden, J. (1990) Am. J. Phys- 
iol. 259, C784~C791. 
[25] K16cker, N., Mu[3hoff, U., Madeja, M. and Speckmann, E.-J. 
(1995) Pfliigers Arch., in press. 
[26] Fraser, S.P., Barrett, P., Djamgoz, M.B.A. and Morgan, P.J. 
(1991) Neurosci. Lett. 124, 242-245. 
